HTGM - HTG Molecular Diagnostics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
19,204
19,204
21,504
14,760
5,133
Cost of Revenue
8,911
8,911
5,090
4,972
4,136
Gross Profit
10,293
10,293
16,413
9,788
996.846
Operating Expenses
Research Development
10,570
10,570
12,598
9,997
7,900
Selling General and Administrative
18,682
18,682
19,975
17,514
17,428
Total Operating Expenses
29,253
29,253
32,573
27,510
25,328
Operating Income or Loss
-18,960
-18,960
-16,159
-17,723
-24,331
Interest Expense
957.535
957.535
901.82
1,308
1,867
Total Other Income/Expenses Net
-
-
-105.064
0.008
56.863
Income Before Tax
-17,133
-19,294
-16,450
-18,957
-26,029
Income Tax Expense
3.379
3.379
3.526
2.921
10.118
Income from Continuing Operations
-19,298
-19,298
-16,454
-18,960
-26,040
Net Income
-19,298
-19,298
-16,454
-18,960
-26,040
Net Income available to common shareholders
-19,298
-19,298
-16,454
-18,960
-26,040
Basic EPS
-
-
-0.60
-1.79
-3.66
Diluted EPS
-
-
-0.60
-1.79
-3.66
Basic Average Shares
-
-
27,523
10,597
7,113
Diluted Average Shares
-
-
27,523
10,597
7,113
EBITDA
-
-16,601
-14,080
-16,408
-22,688